ALT
Price:
$5.31
Market Cap:
$468.65M
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryla...[Read more]
Industry
Biotechnology
IPO Date
2017-05-26
Stock Exchange
NASDAQ
Ticker
ALT
According to Altimmune, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.18. This represents a change of 3.24% compared to the average of 16.64 of the last 4 quarters.
The mean historical Current Ratio of Altimmune, Inc. over the last ten years is 10.58. The current 17.18 Current Ratio has changed 16.13% with respect to the historical average. Over the past ten years (40 quarters), ALT's Current Ratio was at its highest in in the September 2016 quarter at 37.02. The Current Ratio was at its lowest in in the December 2016 quarter at 1.09.
Average
10.58
Median
10.61
Minimum
1.09
Maximum
19.16
Discovering the peaks and valleys of Altimmune, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 463.21%
Maximum Annual Current Ratio = 19.16
Minimum Annual Increase = -86.27%
Minimum Annual Current Ratio = 1.09
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 13.11 | -24.05% |
| 2023 | 17.26 | 52.69% |
| 2022 | 11.31 | 1.23% |
| 2021 | 11.17 | -41.69% |
| 2020 | 19.16 | 90.75% |
| 2019 | 10.04 | 15.47% |
| 2018 | 8.70 | 42.30% |
| 2017 | 6.11 | 463.21% |
| 2016 | 1.09 | -86.27% |
| 2015 | 7.90 | 6.01% |
The current Current Ratio of Altimmune, Inc. (ALT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
13.89
5-year avg
14.40
10-year avg
10.58
Altimmune, Inc.’s Current Ratio is greater than DBV Technologies S.A. (2.45), greater than Annexon, Inc. (5.67), greater than Korro Bio, Inc. (5.98), greater than enGene Holdings Inc. (10.34), greater than Larimar Therapeutics, Inc. (5.46), greater than Aura Biosciences, Inc. (12.39), greater than Amarin Corporation plc (3.45), less than Alto Neuroscience, Inc. (18.43), greater than LB Pharmaceuticals Inc Common Stock (3.56), greater than AC Immune S.A. (1.33),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.45 | $312.18M | |
| 5.67 | $536.98M | |
| 5.98 | $63.86M | |
| 10.34 | $420.82M | |
| 5.46 | $314.97M | |
| 12.39 | $409.59M | |
| 3.45 | $340.44M | |
| 18.43 | $415.67M | |
| 3.56 | $487.01M | |
| 1.33 | $289.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altimmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Altimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Altimmune, Inc.'s Current Ratio?
How is the Current Ratio calculated for Altimmune, Inc. (ALT)?
What is the highest Current Ratio for Altimmune, Inc. (ALT)?
What is the 3-year average Current Ratio for Altimmune, Inc. (ALT)?
What is the 5-year average Current Ratio for Altimmune, Inc. (ALT)?
How does the current Current Ratio for Altimmune, Inc. (ALT) compare to its historical average?